^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    Amplimexon (imexon)

    i
    Other names: BM 06002
    Associations

    News

    Trials
    Company:
    Amplimed Corp
    Drug class:
    Ribonucleotide reductase inhibitor
    Related drugs:
    Associations

    News

    Trials
    3years
    A pan-cancer analysis of the HER family gene and their association with prognosis, tumor microenvironment, and therapeutic targets. (PubMed, Life Sci)
    These findings may elucidate the roles played by HER family gene in cancer progression and providing insights for further investigation of the HER family gene as potential targets in pan-cancer.
    Journal • Pan tumor
    |
    HER-2 (Human epidermal growth factor receptor 2) • ERBB3 (V-erb-b2 avian erythroblastic leukemia viral oncogene homolog 3) • ERBB4 (erb-b2 receptor tyrosine kinase 4)
    |
    HER-2 expression • ERBB4 expression
    |
    dasatinib • tamoxifen • ifosfamide • oxaliplatin • bafetinib (INNO-406) • Amplimexon (imexon) • E7820